Director Ian F. Smith receives 28,000 Foghorn Therapeutics (FHTX) stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Foghorn Therapeutics Inc. director Ian F. Smith received a grant of stock options covering 28,000 shares of common stock at an exercise price of $4.08 per share. These options vest in full on the first anniversary of the grant date, contingent on his continued board service, and expire on June 23, 2036. Following this compensation award, Smith holds 28,000 options directly, and the filing reports no open-market buying or selling activity.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
SMITH IAN F
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to buy) | 28,000 | $4.08 | $114K |
Holdings After Transaction:
Stock Options (Right to buy) — 28,000 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 28,000 options
Exercise price: $4.08 per share
Post-grant holdings: 28,000 options
+2 more
5 metrics
Options granted
28,000 options
Stock options covering common stock granted to director
Exercise price
$4.08 per share
Exercise price for the 28,000 stock options
Post-grant holdings
28,000 options
Total derivative securities held following the grant
Vesting schedule
100% after 1 year
Vests in full on first anniversary of grant date
Expiration date
June 23, 2036
Option expiration date for the 28,000 options
Key Terms
Stock Options (Right to buy), grant, award, or other acquisition, exercise price, vests in full, +1 more
5 terms
Stock Options (Right to buy) financial
"security_title: Stock Options (Right to buy)"
grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
exercise price financial
"conversion_or_exercise_price: 4.0800"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vests in full financial
"The option vests in full on the first anniversary of the grant date"
expiration date financial
"expiration_date: 2036-06-23T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What insider transaction did Foghorn Therapeutics (FHTX) report for Ian F. Smith?
Foghorn Therapeutics reported a stock option grant to director Ian F. Smith. He received options for 28,000 shares of common stock as a compensation award, rather than buying shares on the market, according to the Form 4 filing.
What is the exercise price of Ian F. Smith’s Foghorn Therapeutics stock options?
The exercise price of Ian F. Smith’s options is $4.08 per share. This means he can purchase Foghorn Therapeutics common stock at $4.08 per share once the options vest and before they expire.
When do Ian F. Smith’s Foghorn Therapeutics stock options vest?
The options vest in full on the first anniversary of the grant date. Vesting is subject to Smith’s continued service on the company’s board of directors, aligning his compensation with ongoing governance responsibilities.
When do Ian F. Smith’s Foghorn Therapeutics stock options expire?
The stock options expire on June 23, 2036, if not exercised earlier. After this expiration date, Smith would no longer be able to use the options to purchase Foghorn Therapeutics common stock at the exercise price.